A Study of LY3200882 in Participants With Solid Tumors
Trial Status: closed to accrual
The main purpose of this study is to evaluate the safety of the study drug known as LY3200882 in participants with solid tumors.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
The main purpose of this study is to evaluate the safety of the study drug known as LY3200882 in participants with solid tumors.